25 of the Best Oncologists Near Me

Dr. Schlam received her medical degree from Anahuac University in Mexico City in 2014. She subsequently completed her Internal Medicine residency at The Jewish Hospital of Cincinnati and then her Hematology and Medical Oncology fellowship at The MedStar Georgetown Washington Hospital Center in Washington, DC. She obtained her Masters in Public Health from the Harvard School of Public Health in 2024. She was faculty at Tufts Medical Center from 2021 to 2024. In 2024, she joined the staff of the Dana-Farber Cancer Institute as a breast medical oncologist and clinical researcher. Her research focuses on drug development, identifying markers of response to novel therapies and healthcare disparities. Dr. Camhi is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Camhi is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Camhi is currently accepting new patients.

Rachel Kramer is an Oncologist practicing medicine in New York, New York. Dr. Kramer is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Vitamin B12 Deficiency, Thrombocytopenia, Inflammatory Breast Cancer, and Relapsing Multiple Sclerosis (RMS). Dr. Kramer is currently accepting new patients.

Yaseen Alkaddoumi is a Hematologist and an Oncologist practicing medicine in Orland Hills, Illinois, Illinois. Dr. Alkaddoumi is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Alkaddoumi is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Alkaddoumi is currently accepting new patients.

Daniel King, MD PhD, is a gastrointestinal medical oncologist based at the Monter Cancer Center and Director of Research and Development for the Northwell Health Cancer Institute's Center for Genomic Medicine. As an academic oncologist and active researcher, he aims to deliver the latest advances uncovered through clinical trials, breakthrough technologies, and targeted therapies, to his patients. Prior to completing medical school, he pursued scientific investigation aimed at uncovering the underpinnings of cancer. These experiences included a fellowship as a Howard Hughes Research Scholar at the National Institutes of Health and as a PhD student at the Wellcome Sanger Genomic Institute at the University of Cambridge, UK, where he studied genomics and bioinformatics. More recently, Dr. King trained in medical oncology at Stanford University where he conducted translational research in pancreatic cancer and has published in peer reviewed journals. At Northwell, in addition to his active medical practice, he conducts clinical research in partnership with Cold Spring Harbor Laboratory, where he is a clinical scholar in the laboratory of Dr. Dave Tuveson. Dr. King is board certified in Internal Medicine and Medical Oncology and is an active member of the American Association of Cancer Research. Dr. King is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Ampullary Cancer, and Familial Colorectal Cancer. Dr. King is board certified in American Board Of Internal Medicine/Medical Oncology and American Board Of Internal Medicine. Dr. King is currently accepting new patients.

Philosophy of care | I believe every patient deserves care personalized to their goals and wishes. My mission is to ensure you are treated as an individual. | Why I entered medicine | I entered medicine to improve the health of my community. I grew up in Northeastern Pennsylvania and it is my great pleasure to be able to give back to the community that raised me. | Community involvement | I enjoy staying active within my community and in improving its health. | Personal interests | I like biking, violin and taking time for personal fitness. Dr. Decker is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Decker is board certified in American Board Of Internal Medicine - Internal Medicine , American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Hematology . Dr. Decker is currently accepting new patients.

Avram Abramowitz is a Hematologist and an Oncologist practicing medicine in Rego Park, New York. Dr. Abramowitz is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Anemia, Vitamin B12 Deficiency, and Malabsorption. Dr. Abramowitz is board certified in American Board Of Internal Medicine/Medical Oncology and American Board Of Internal Medicine. Dr. Abramowitz is currently accepting new patients.

Zahra Rahman Kelly, DO, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Kelly is trained in the management of all cancers and blood disorders with a focus in genitourinary and head and neck malignancies. Dr. Kelly is board-certified in nternal medicine and medical oncology and hematology. She received her medical degree from Philadelphia College of Osteopathic Medicine. Dr. Kelly completed both a residency in internal medicine and a fellowship in hematology/oncology at UPMC. She served as chief fellow during her final year of hematology/oncology fellowship.Her research interests include early phase clinical trial design and cancer immunotherapy combination trials. She has published papers in peer reviewed journals and is an active member of the UPMC Hillman protocol review committee where she reviews therapeutic oncology trials. She also collaborates with surgical oncologists and radiation oncologists to provide multidisciplinary care to her patients.Dr. Kelly is a member of the European Society of Medical Oncology, American Society of Medical Oncology, American Medical Association, and American Society of Hematology. Dr. Kelly is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Febrile Neutropenia, Agranulocytosis, and Gamma Knife Radiosurgery. Dr. Kelly is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Kelly is currently accepting new patients.

Dov Kadmon, M.D., is a Board-certified urologist and Professor of Urology at BCM. His practice is focused on the diagnosis and treatment of prostate cancer. He is an experienced surgeon, who has performed over 1,000 open radical prostatectomies and over 1,000 robotic-assisted (da Vinci) laparoscopic radical prostatectomies. He offers his patients state-of-the-art surgical techniques as well as an operation tailored to each individual's special needs. Dr. Kadmon has an extensive record of prostate cancer research, both basic science and clinical. He is recognized nationally and internationally for his contributions to the field and has published over 150 papers in the medical literature. He was awarded numerous grants by the National Cancer Institute to support his research and has served as a consultant to the NCI on the topic of prostate cancer. Dr. Kadmon is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Vasectomy, and Prostatectomy. Dr. Kadmon is currently accepting new patients.

Ruoyu Miao is an Oncologist practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 18 years. Dr. Miao is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Chordoma, Osteosarcoma, and Rhabdomyosarcoma. Dr. Miao is board certified in American Board Of Internal Medicine, 2024. Dr. Miao is currently accepting new patients.

Dr. Saoud serves as an assistant professor of urology and urologic oncology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. His area of expertise includes the management of urological cancers such as prostate, kidney, bladder, testicular, and penile cancers, employing advanced surgical techniques like robotic, endoscopic, and open surgery. In addition to oncology, he addresses various urological conditions, including benign prostatic hyperplasia, erectile dysfunction, and kidney and bladder stones.Inspired by his family, many of whom are medical professionals, Dr. Saoud pursued a career in medicine, embodying the values of compassion and dedication he observed from an early age. His medical training began with a residency at the American University of Beirut Medical Center, completed in 2018, followed by specialized fellowship training in abdominal organ transplant and urologic oncology at the University of Chicago Medicine.Originating from Lebanon, Dr. Saoud has extended his commitment to healthcare through volunteer work, offering medical services to refugees and underserved populations. These experiences have profoundly influenced his approach to empathetic patient care.Dr. Saoud is dedicated to involving patients in their treatment planning, ensuring they are well-informed about their health options. He advocates for patient autonomy and individualized care, believing in the importance of preventive measures and a strong patient-provider relationship to achieve optimal health outcomes. Dr. Saoud is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Teratoma of the Mediastinum, Testicular Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Nephrectomy. Dr. Saoud is currently accepting new patients.

Brittney Zimmerman is an Oncologist practicing medicine in Greenlawn, New York. Dr. Zimmerman is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Breast Cancer, Inflammatory Breast Cancer, and Thrombocytopenia. Dr. Zimmerman is board certified in American Board Of Internal Medicine/Medical Oncology and American Board Of Internal Medicine. Dr. Zimmerman is currently accepting new patients.

Dr. Michelle Ludwig is a radiation oncologist. She is an Associate Professor of Radiation Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. She is also an Adjunct Assistant Professor of Human Genetics & Environmental Sciences, Division of Epidemiology at the UTHealth School of Public Health in Houston.Dr. Ludwig completed undergraduate studies at Purdue University in Lafayette, Indiana and received her medical degree from Emory University School of Medicine in Atlanta. She received her MPH from the Emory Rollins School of Public Health in Atlanta and her Ph.D. from the University of Texas Health Science Center in Houston. She completed her residency at the M.D. Anderson Cancer Center and a clinical fellowship at The University of Texas, Houston Medical Program and M.D. Anderson Cancer Center. Dr. Ludwig is board-certified in Radiation Oncology by the American Board of Radiology. In addition to English, Dr. Ludwig speaks Spanish. Dr. Ludwig is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Triple-Negative Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Malignant Mixed Mullerian Tumor. Dr. Ludwig is currently accepting new patients.

Dr. Yoanna Pumpalova is an Assistant Professor of Medicine and medical oncologist at Columbia University Irving Medical Center where she specializes in the treatment of gastrointestinal malignancies, with a focus on colorectal and anal cancers. She received her MD from Weill Cornell Medical College and completed internship and residency training in Internal Medicine and Global Health at Stanford University. She then completed fellowship training in Medical Oncology at Columbia University/New York Presbyterian Hospital. Dr. Pumpalova works as part of a multidisciplinary team with the mission of delivering compassionate and state-of-the-art oncologic care to each patient, using a precision medicine approach to provide innovative and promising treatments.Dr. Pumpalova is actively involved in translational research to understand the biological mechanisms driving early onset colorectal cancer. She collaborates with Dr. Joel Gabre, a gastroenterologist and clinician scientist and Dr. Beatrice Dionigi, colorectal surgeon, on research to understand how early onset colorectal cancer differs from average onset colorectal cancer, with the goal of uncovering novel ways to treat all patients with colorectal cancer. Dr. Pumpalova is also the site principal investigator of industry-sponsored clinical trials investigating novel therapies for the treatment of colorectal cancer. Further, Dr. Pumpalova conducts studies in low- and middle-income countries focused on early detection and screening for colorectal cancer. She has active studies in South Africa and Dominican Republic. Her research goal is to improve outcomes for patients diagnosed with colorectal cancer, regardless of where they reside. Her work has been recognized by several awards including an ASCO Young Investigator Award and ASCO Career Development Award.In the NewsColumbia Researchers Seek Answers for Rise of Colon Cancer in Younger PatientsWhat to Know About the Rise of Colorectal Cancer in Younger PeopleExploring Strategies for Earlier Colon Cancer Detection in Sub-Saharan Africa. Dr. Pumpalova is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Anal Cancer, Familial Colorectal Cancer, Colonoscopy, and Endoscopy. Dr. Pumpalova is currently accepting new patients.

Aliyah Pabani, M.D., M.P.H. is an Assistant Professor of Oncology at the Sidney Kimmel Comprehensive Cancer at Johns Hopkins in the Upper Aerodigestive Cancer Division (UAD). She is Co-Director of the Immune-Related (IR) Toxicity Team. Dr. Pabani completed Internal Medicine residency and Medical Oncology fellowship at the University of Alberta after which she pursued an Advanced Thoracic Oncology fellowship at Columbia University. She also received a Masters of Public Health from Harvard University. Dr. Pabani conducts clinical and translational research in immunotherapy-related adverse events and immunotherapy in squamous cell cancers. She cares for patients primarily at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Skip Viragh Outpatient Cancer Center and Johns Hopkins Bayview Medical Center. Dr. Pabani is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Melanoma, and Small Cell Lung Cancer (SCLC). Dr. Pabani is board certified in Royal College Of Physicians And Surgeons Of Canada. Dr. Pabani is currently accepting new patients.

Daniel T. Friedman, MD, is Director, Community Hematology/Oncology at Montefiore Einstein and Assistant Professor, Medical Oncology at our Albert Einstein College of Medicine. He delivers community-focused care for hematology and medical oncology patients in the Bronx and Yonkers. Dr. Friedman is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Acquired Agranulocytosis, Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Thrombocytopenia, and Endoscopy. Dr. Friedman is currently accepting new patients.

Laura Meza Rios, MD is board certified in internal medicine and specializes in medical oncology and hematology. Dr. Rios attended medical school at Universidad Industrial de Santander in Colombia graduating in 2005. She completed residency at Rochester Regional Health in Rochester, NY. Prior to moving to Houston she worked as an academic hospitalist for a year after graduating from residency. She completed her Hematology/ Oncology fellowship at Baylor College of Medicine. Dr. Rios is passionate about gastroenterology oncology and frequently treats colon, rectal, pancreatic, liver and gastric cancer. She is also known to treat other conditions such as lung and breast cancer, as well as lymphomas, myelomas and other solid organ cancers. Dr. Rios provides individualized care to each of her patients. She is passionate about learning about her patients and what is important to them when creating a treatment plan. When Dr. Rios is not treating patients, she loves spending time with her family outdoors, biking and cooking for special occasions. Dr. Rios joined the faculty at the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine in August 2020 and is accepting new patients. Dr. Rios is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Anemia, and Sickle Cell Disease. Dr. Rios is currently accepting new patients.

"Dr. Patrick C. Walsh is a professor of urology at the Johns Hopkins School of Medicine. He is recognized internationally as a pioneer in the diagnosis and treatment of prostate cancer. Dr. Walsh is best known for his pioneering work in the development of ""the anatomic approach to radical prostatectomy,"" which involves nerve-sparing techniques that have reduced the probability of impotence and incontinence, and for his 30 years as director of the Brady Urological Institute. He has also made major contributions to the basic understanding of benign and malignant neoplasms of the prostate. Along with co-workers, he was the first to describe the 5 alpha-reductase enzyme deficiency, to develop an experimental technique for the induction of benign prostatic hyperplasia, to demonstrate the influence of reversible androgen deprivation on BPH, and to characterize hereditary prostatic cancer. Dr. Walsh received his undergraduate and medical training at Case Western Reserve University. After an internship and junior residency in surgery at the Peter Bent Brigham Hospital in Boston, he conducted an assistant residency in pediatric surgery at The Children''s Hospital Medical Center in Boston, and a residency in urology as well as a fellowship in endocrinology at the University of California Los Angeles, School of Medicine. He joined the faculty of Johns Hopkins in 1974. In 2004 he was named University Distinguished Service Professor of Urology. Dr. Walsh has received dozens of national and international awards and honors. He has authored or co-authored more than 600 articles and three books, including a best-seller for lay people titled The Prostate: A Guide for Men and the Women Who Love Them. For 25 years he was the editor-in-chief of Campbell''s Textbook of Urology, which has been renamed in his honor. He is on the editorial board of the New England Journal of Medicine, is a member of numerous international professional organizations and has served as the president of both the American Association of Genitourinary Surgeons and the Clinical Society of Genitourinary Surgeons.". Dr. Walsh is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer and Prostate Cancer. Dr. Walsh is currently accepting new patients.

Yazan Numan is a Hematologist and an Oncologist practicing medicine in Orland Hills, Illinois, Illinois. Dr. Numan is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Acute Myeloid Leukemia (AML), Leukemia, and Bone Marrow Aspiration. Dr. Numan is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Numan is currently accepting new patients.

Arielle Katcher is an Oncologist practicing medicine in Newark, Delaware. Dr. Katcher is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Cervical Cancer, Malignant Mixed Mullerian Tumor, and Pelvic Congestion Syndrome. Dr. Katcher is currently accepting new patients.

Roberto Alejandro Sica, MD, is an Attending Physician at Montefiore and an Assistant Professor of Medicine at our Albert Einstein College of Medicine. Since joining the Montefiore team, Dr. Sica’s clinical focus has been on chimeric antigen receptor (CAR) T-cell therapies, immunotherapies and allogeneic stem cell transplantation, central nervous system (CNS) lymphomas and HIV, ATLL and gene therapy for malignant and nonmalignant hematologic disorders. Dr. Sica is a member of the Bone Marrow Transplant team at Montefiore. Dr. Sica is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Chronic T-Cell Leukemia (CTCL), Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Sica is currently accepting new patients.

Rehana Bhuiyan is an Oncologist practicing medicine in Wilkes Barre, Pennsylvania. Dr. Bhuiyan is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma. Dr. Bhuiyan is currently accepting new patients.

John Doweiko is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Doweiko is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Seasonal Affective Disorder (SAD), and Chronic B-Cell Leukemia (CBCL). Dr. Doweiko is board certified in American Board Of Internal Medicine. Dr. Doweiko is currently accepting new patients.

Dr. Meznarich received her medical degree from the University of Washington School of Medicine in Seattle, Washington. She then completed her residency in Pediatrics and fellowship in Pediatric Hematology and Oncology at the University of Utah/Primary Children's Hospital in Salt Lake City, Utah.She joined the faculty of the University of Utah in 2016, where she is currently an Associate Professor of Pediatrics in the Division of Pediatric Hematology and Oncology.  Her clinical and research interests are in non-malignant hematology, bleeding disorders, thrombosis and clotting disorders, and hemoglobinopathies including thalassemia and sickle cell disease. Dr. Meznarich is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Anemia, Hemolytic Anemia, Congenital Hemolytic Anemia, and Pure Red Cell Aplasia. Dr. Meznarich is board certified in American Board Of Pediatrics, American Board Of Pediatrics , and American Board Of Pediatrics. Dr. Meznarich is currently accepting new patients.

Mark Abate is an Oncologist practicing medicine in Santa Barbara, California. Dr. Abate is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Transthyretin Amyloid Cardiomyopathy, Hemangioma Thrombocytopenia Syndrome, Breast Cancer, and Bone Marrow Aspiration. Dr. Abate is currently accepting new patients.

Jacob Berchuck is an Oncologist practicing medicine in Atlanta, Georgia. Dr. Berchuck is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Small Cell Lung Cancer (SCLC), Tissue Biopsy, and Prostatectomy. Dr. Berchuck is board certified in American Board Of Internal Medicine, 2020. Dr. Berchuck is currently accepting new patients.